Vaccine Supply Challenges

Stéphane faced immense pressure as he sought to secure billions in funding to ramp up production for the vaccine. Suppliers were hesitant, requiring upfront payments for the massive quantities of raw materials needed, which added to the urgency of the situation. The stakes extended beyond financial risk; the success of the vaccine hinged on overcoming these critical supply chain obstacles.